BCX4208

DRUG2 trials

Sponsors

BioCryst Pharmaceuticals

Conditions

Gout

Phase 2

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

CompletedNCT00985127

BioCryst PharmaceuticalsGout

Start: 2009-09-30End: 2010-09-30Updated: 2012-01-23

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

CompletedNCT01129648

BioCryst PharmaceuticalsGout

Start: 2010-05-31End: 2010-11-30Updated: 2012-01-23